[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350403-105":59,"doc-detail-350403-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-alternative-splicing-in-gastric-cancer","The role of alternative splicing in gastric cancer","","Gastric cancer (GC) remains a major cause of cancer incidence and mortality worldwide. Alternative splicing (AS), a post-transcriptional mechanism that expands transcript diversity from a single pre-mRNA, plays critical regulatory roles in GC. This review summarizes current knowledge of AS in GC, highlighting how aberrant splicing contributes to oncogenesis, progression, invasion, metastasis, and drug resistance. Reported AS-related biomarkers such as RBM4 and subtype prognostic models exist, but patient-level validation and standardized detection workflows are still limited. Future efforts should emphasize prospective cohorts and standardized pipelines.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-alternative-splicing-in-gastric-cancer/350403/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-alternative-splicing-in-gastric-cancer/350403.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of alternative splicing in gastric cancer?","Question",{"text":112,"@type":113},"Alternative splicing expands transcript diversity from single pre-mRNA and acts as a critical regulatory mechanism in gastric cancer. Aberrant alternative splicing contributes to oncogenesis, progression, invasion, metastasis, and drug resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What kinds of alternative splicing are discussed?",{"text":117,"@type":113},"The review describes five types of alternative splicing: exon skipping, alternative donor site, alternative acceptor site, mutually exclusive exons, and retained intron.",{"name":119,"@type":110,"acceptedAnswer":120},"What limitations exist in current studies and what should future research focus on?",{"text":121,"@type":113},"Most studies emphasize basic research, while patient-level validation remains limited and standardized detection and analysis workflows are lacking. Future work should prioritize prospective cohorts and standardized pipelines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350403,1790792031,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Huang et al. Biology Direct (2026) 21:97 [https://doi.org/10.1186/s13062-026-00813-4](https://doi.org/10.1186/s13062-026-00813-4)  \nBiology Direct  \nREVIEW Open Access  \nThe role of alternative splicing in gastric cancer  \nQichen Huang1,2†, Junyu Ke1,2†, Xinrui Shen1,2†, Yitian Xu1,2, Sijun Sun1,2 and Chen Huang1,2*  \nAbstract  \nGastric cancer (GC) remains a major cause of cancer incidence and mortality worldwide. Alternative splicing (AS), a post-transcriptional mechanism that expands transcript diversity from a single pre-mRNA, plays critical regulatory roles in GC. This review summarizes the current knowledge of AS in GC. Accumulating evidence shows that aberrant AS contributes to the oncogenesis, progression, invasion, metastasis and drug resistance of GC. In addition, AS-related biomarkers like RBM4 and prognostic models for subtype prediction have been reported. However, most existing studies have focused on basic research, while patient-level validation remains limited and standardized detection and analytical workflows are still lacking. Future work should prioritize prospective cohortsand standardized pipelines.  \nKeywords Gastric cancer, Alternative splicing, Splicing variant, RNA processing  \nIntroduction  \nGastric cancer (GC) remains a major clinical challenge, ranking fifth in global cancer incidence (4.9%) and mortality (6.8%) [1]. Because early-stage disease is often clinically silent, GC is frequently diagnosed at an advanced stage. Researchers have therefore investigated diverse aspects of GC, including gene mutations, signaling pathways, circular RNA, and the tumor microenvironment, to better understand its biology. Interest in alternative splicing (AS) has grown steadily. AS generates transcript diversity from a single pre-mRNA and was independently  \n†Qichen Huang, Junyu Ke and Xinrui Shen contributed equally to this work.  \n*Correspondence:  \nChen Huang  \n[richard-hc@hotmail.com](richard-hc@hotmail.com)  \n1Department of Gastrointestinal Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai  \n200080, China  \n2Institute of Gastrointestinal Tumor Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai  \n200080, China  \ndiscovered by Phillip Sharp and Richard Roberts in 1977. Since then, AS has been recognized as an important regulator of cancer and cellular metabolism. With advancesin RNA sequencing, spatial transcriptomics, and bioinformatics, more splicing variants and their disease associations have been identified.  \nAS alterations are particularly prominent in GC [2], and the study of AS in GC has a long history. Over the past three decades, researchers have identified numerous AS-associated genes such as CD44 and BIRC5, clarified mechanisms through which AS affects GC, and proposed predictive models and therapeutic strategies. More recently, AS has been shown to interact with other epigenetic regulatory layers to promote GC progression [3]. Collectively, current studies highlight the potential of AS in explaining GC metastasis, tumor microenvironment remodeling, and tumor heterogeneity, while also supporting its use as a diagnostic and therapeutic target.  \nCompared with prior reviews, this article adds additional value in three aspects. First, it incorporates recent evidence from 2023 to 2025 to update the landscape of alternative splicing in gastric cancer. Second, it integrates  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The","cbCaivH5QVppBXbv","https://ap.wps.com/l/cbCaivH5QVppBXbv","pdf",1485779,11,"English","# Introduction\n## Mechanisms of alternative splicing\n## Types of alternative splicing","[{\"question\":\"What is the role of alternative splicing in gastric cancer?\",\"answer\":\"Alternative splicing expands transcript diversity from single pre-mRNA and acts as a critical regulatory mechanism in gastric cancer. Aberrant alternative splicing contributes to oncogenesis, progression, invasion, metastasis, and drug resistance.\"},{\"question\":\"What kinds of alternative splicing are discussed?\",\"answer\":\"The review describes five types of alternative splicing: exon skipping, alternative donor site, alternative acceptor site, mutually exclusive exons, and retained intron.\"},{\"question\":\"What limitations exist in current studies and what should future research focus on?\",\"answer\":\"Most studies emphasize basic research, while patient-level validation remains limited and standardized detection and analysis workflows are lacking. Future work should prioritize prospective cohorts and standardized pipelines.\"}]","The role of alternative splicing in gastric cancer | PDF",1790088897,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d21d8c45ddc46e7cbcebfd07a2bbca0a.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f4389812740bb7dee659d5d18e7498e.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dcccea97d0071704be2a9addbe049d8.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82397f6c5c6f354e89dde2678a348601.webp",980,1306]